Black Box reported a 18% year-on-year increase in Q1 FY27 consolidated net profit to Rs 55.9 crore, while revenue from operations rose 24% to Rs 1,719 crore. On a sequential basis, net profit fell 14% from Rs 64.8 crore in Q4 FY26 even as revenue increased 1.6% from Rs 1,691 crore, reflecting higher expenses and exceptional costs during the June quarter. The board has recommended a final dividend of Re 1 per equity share, and total expenses increased 23% year-on-year to Rs 1,653 crore.

Titan reported a strong first-quarter performance, with jewellery revenue up 38% year on year and EBIT rising 33%. Reported profit increased 65%, aided by a ₹386 crore customs-duty benefit and mark-to-market gains. The shares rose 1.5% in early trade on Monday, making Titan the top gainer in the Nifty 50. Citi said it expects growth and profitability to remain strong and lifted its FY27–FY29 EPS estimates by 5–10%.

Zydus Wellness reported consolidated net profit of ₹118.9 crore for Q1 FY27, down 7.03% year on year. Revenue rose 67% to ₹1,437 crore. Basic EPS came in at ₹3.74 versus ₹4.02 a year earlier. The company also said its trading window will remain closed until 6 August 2026.

Krishna Institute of Medical Sciences (KIMS) reported a 47.2% year-on-year drop in consolidated net profit to Rs 41.5 crore for Q1 FY27, even as revenue from operations rose 35.3% to Rs 1,179.5 crore. EBITDA increased 16% to Rs 223.4 crore, while the EBITDA margin narrowed to 18.9% from 22.1%. The company said it began FY27 on a strong note and launched a new hospital in Palakkad, Kerala.

India’s securities regulator SEBI fined SME-listed Kalahridhaan Trendz and its promoters a total of Rs 1 crore, finding the company concealed a default on HDFC Bank credit card dues. SEBI also said the company made a false disclosure of an export order worth Rs 115.5 crore from Bangladesh-based Beximcorp Textiles without adequate due diligence. The action, taken under the LODR framework, targets disclosure lapses and governance failures and tightens scrutiny on India’s SME segment.

Sun Pharmaceutical Industries reported a 27% year-on-year rise in consolidated net profit in Q1 FY27, while revenue grew 10.1% to ₹15,183.55 crore. India formulations sales climbed 16% to ₹5,474.9 crore and made up 36.1% of consolidated sales, while US revenue fell 9.7%. EBITDA increased 2.7% year on year to ₹4,417.7 crore, with a margin of 28.9%.

Aditya Birla Capital Limited reported consolidated Q1 FY27 results for the quarter ended 30 June 2026, with net profit rising 40% year on year to ₹1,174.7 crore. Revenue from operations increased 29% to ₹12,179.54 crore. Basic earnings per share rose to ₹4.46 from ₹3.22 a year earlier.

Century Plyboards reported consolidated net profit of ₹83.30 crore for the first quarter of fiscal year 2027, up 57% from a year earlier. Revenue from operations rose 33.52% to ₹1,561.38 crore. Earnings per share increased to ₹3.61.

Kirloskar Brothers reported consolidated Q1 FY27 net profit after tax of ₹66.7 crore, down 5.4% year on year. Revenue from operations rose 12.86% to ₹1,104.9 crore. Basic and diluted EPS came in at ₹8.39, slightly below ₹8.40 a year earlier. The results show profit growth trailing revenue growth, potentially reflecting cost pressure or changes in product mix.